Greenland Mines Ltd

GRMLW

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

About Cashu Markets Contact

Legal

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

–

USD

–(–)

Open

$0.20

Prev. Close

$0.17

High

$0.21

Low

$0.20

Company Profile

Greenland Mines Ltd. specializes in developing innovative treatments for neurodegenerative disorders. Their therapeutic pipeline includes both cell and gene therapies. Joseph Sinkule established the company on August 2, 2004, and it is presently headquartered in Omaha, Nebraska.

CEOJoseph A. Sinkule

SectorBasic Materials

IndustryOther Precious Metals

Employees3

IPO DateApr 29, 2022

ExchangeNASDAQ

Exchange NameNASDAQ Global Market

CurrencyUSD

Headquarters & Contact

Address13576 Walnut Street

City / State / ZIPOmaha, NE, 68144

CountryUnited States

Phone833 931 6330

Websitehttps://greenlandmines.com

Greenland Mines Ltd

Company Profile

Recently from Cashu